During the past decade, Halifax Infirmary conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Halifax Infirmary" #1 sponsor was "Nova Scotia Health Authority" with 4 trials, followed by "Ross Leighton" with 3 trials sponsored, "Dalhousie University" with 2 trials sponsored, "NoNO Inc." with 2 trials sponsored and "Population Health Research Institute" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Halifax Infirmary" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Nova Scotia Health Authority" with 3 trials as a collaborator, "Almirall, SAS" with 1 trials as a collaborator, "Arbor Vita Corporation" with 1 trials as a collaborator and "Arthrex, Inc." with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Halifax Infirmary" are "Stroke" (3 trials), "Atrial Fibrillation" (2 trials), "COPD" (2 trials), "Osteoarthritis" (2 trials) and "Amyloid Cardiomyopathy" (1 trials). Many other conditions were trialed in "Halifax Infirmary" in a lesser frequency.

Most popular intervention types in "Halifax Infirmary" are "Drug" (7 trials), "Device" (6 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "NA-1" (2 trials), "Placebo" (2 trials), "90yttrium colloid" (1 trials), "Advance Biofoam porous metal backed tibial component with or without screw augmentation" (1 trials) and "Calcium Sulfate + Antibiotics + Internal Fixation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Halifax Infirmary" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Halifax Infirmary". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Halifax Infirmary, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Halifax Infirmary, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".